Fig. 1From: A novel sub-regional radiomics model to predict immunotherapy response in non-small cell lung carcinomaOverview of the workflow in our study. PD-L1 programmed death-ligand 1, PFSÂ progression-free survival, SVMÂ support vector machine, ROI region of interest, TMB tumor mutational burdenBack to article page